Skip to content

Gyre Therapeutics, Inc. GYRE Book value per share

Book value per share at other companies

Eli Lilly logo
Eli LillyLLY
$34.82+98.9%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$18.72-26.0%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$4.34-42.5%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$5.67+69.7%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$20.31+1,888%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$3.42+351%

Other financials

Income statement

See full
Revenue$22.5M+2.1%
Gross profit$21.3M+0.6%
Operating income-$9.4M-512%
Net income-$8.7M-422%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$37.5M+149%
Total debt$823.0K-48.1%
Total equity$101.3M+48.7%
Total assets$162.0M+24.8%

Cash flow

See full
Operating cash flow$3.2M+2,565%
CapEx$178.0K+45.9%
Free cash flow$3.0M+1,296%

Valuation

See full
Market cap$694.58M-4.7%
Enterprise value$657.9M-8.0%
P/S5.9×-1.3×

Profitability

See full
Gross margin95.1%-1.1pp
Operating margin-0.1%-10.4pp
Net margin6.3%+3.3pp
FCF margin2.6%

Returns & leverage

See full
Return on equity8.2%+4.2pp
Debt / equity0.0×
Current ratio4.6×+1.0×

Where this comes from

Calculated from Gyre Therapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s book value per share?
Gyre Therapeutics, Inc. (GYRE) reported book value per share of $1.11 in Q1 2026.
How has Gyre Therapeutics, Inc.'s book value per share changed year-over-year?
Gyre Therapeutics, Inc.'s book value per share increased by 66.0% year-over-year, from $0.67 to $1.11.
What is the long-term trend for Gyre Therapeutics, Inc.'s book value per share?
Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s book value per share has grown at a -23.7% compound annual growth rate (CAGR), from $3.97 to $1.03.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.